Literature DB >> 8254053

Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.

D Pinsky1, M Oz, H Liao, S Morris, J Brett, R Sciacca, M Karakurum, M Van Lookeren Campagne, J Platt, R Nowygrod.   

Abstract

Current organ preservation strategies subject graft vasculature to severe hypoxia (PO2 approximately 20 Torr), potentially compromising vascular function and limiting successful transplantation. Previous work has shown that cAMP modulates endothelial cell (EC) antithrombogenicity, barrier function, and leukocyte/EC interactions, and that hypoxia suppresses EC cAMP levels. To explore the possible benefits of cAMP analogs/agonists in organ preservation, we used a rat heterotopic cardiac transplant model; dibutyryl cAMP added to preservation solutions was associated with a time- and dose-dependent increase in the duration of cold storage associated with successful graft function. Preservation was also enhanced by 8-bromo-cAMP, the Sp isomer of adenosine 3',5'monophosphorothioate, and types III (indolidan) and IV (rolipram) phosphodiesterase inhibitors. Neither butyrate alone nor 8-bromoadenosine were effective, and the cAMP-dependent protein kinase antagonist Rp isomer of adenosine 3',5'monophosphorothioate prevented preservation enhancement induced by 8-bromo-cAMP. Grafts stored with dibutyryl cAMP demonstrated a 5.5-fold increase in blood flow and a 3.2-fold decreased neutrophil infiltration after transplantation. To explore the role of cAMP in another cell type critical for vascular homeostasis, vascular smooth muscle cells were subjected to hypoxia, causing a time-dependent decline in cAMP levels. Although adenylate cyclase activity was unchanged, diminished oxygen tensions were associated with enhanced phosphodiesterase activity (59 and 30% increase in soluble types III and IV activity, respectively). These data suggest that hypoxia or graft ischemia disrupt vascular homeostasis, at least in part, by perturbing the cAMP second messenger pathway. Supplementation of this pathway provides a new approach for enhancing cardiac preservation, promoting myocardial function, and maintaining vascular homeostatic properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254053      PMCID: PMC288503          DOI: 10.1172/JCI116922

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Prolonged rat cardiac preservation with UW lactobionate solution.

Authors:  L Makowka; T R Zerbe; F Chapman; S G Qian; H Sun; N Murase; R Kormos; J Snyder; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

2.  Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury.

Authors:  C Chang-Chun; H Matsuda; Y Sawa; M Kaneko; N Sakagoshi; M Nishimura; T Kuratani; A Amemiya; Y Kawashima
Journal:  Ann Thorac Surg       Date:  1991-09       Impact factor: 4.330

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  No reflow revisited.

Authors:  R A Kloner
Journal:  J Am Coll Cardiol       Date:  1989-12       Impact factor: 24.094

5.  Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia.

Authors:  K Tanaka; F Gotoh; Y Fukuuchi; T Amano; D Uematsu; J Kawamura; T Yamawaki; N Itoh; K Obara; K Muramatsu
Journal:  Stroke       Date:  1989-05       Impact factor: 7.914

6.  Protection by verapamil in the calcium paradox: dependence on micromolar calcium.

Authors:  A N Oksendal; P Jynge
Journal:  Cardiovasc Res       Date:  1986-11       Impact factor: 10.787

7.  Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.

Authors:  B R Boggs; D F Torchiana; G A Geffin; J S Titus; B E Redonnett; D D O'Keefe; J B Newell; W M Daggett
Journal:  J Thorac Cardiovasc Surg       Date:  1987-06       Impact factor: 5.209

8.  Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties.

Authors:  S Ogawa; H Gerlach; C Esposito; A Pasagian-Macaulay; J Brett; D Stern
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

9.  Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogues.

Authors:  M C Marivet; J J Bourguignon; C Lugnier; A Mann; J C Stoclet; C G Wermuth
Journal:  J Med Chem       Date:  1989-07       Impact factor: 7.446

10.  Alterations in oxidative function and respiratory regulation in the post-ischemic myocardium.

Authors:  S D Zimmer; K Uğurbil; S P Michurski; P Mohanakrishnan; V K Ulstad; J E Foker; A H From
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

View more
  10 in total

Review 1.  Therapeutic targets for hypoxia-elicited pathways.

Authors:  C T Taylor; S P Colgan
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

2.  cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression.

Authors:  Hui Liao; Matthew C Hyman; Amy E Baek; Keigo Fukase; David J Pinsky
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

Review 3.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.

Authors:  D J Pinsky; Y Naka; H Liao; M C Oz; D D Wagner; T N Mayadas; R C Johnson; R O Hynes; M Heath; C A Lawson; D M Stern
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

5.  Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass.

Authors:  M Chello; P Mastroroberto; G Patti; A D'Ambrosio; M Cortez Morichetti; G Di Sciascio; E Covino
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

6.  Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke.

Authors:  E S Connolly; C J Winfree; T A Springer; Y Naka; H Liao; S D Yan; D M Stern; R A Solomon; J C Gutierrez-Ramos; D J Pinsky
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

7.  Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway.

Authors:  D J Pinsky; M C Oz; S Koga; Z Taha; M J Broekman; A J Marcus; H Liao; Y Naka; J Brett; P J Cannon
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 8.  Pharmacological treatment of chronic pelvic ischemia.

Authors:  Karl-Erik Andersson; Masanori Nomiya; Norifumi Sawada; Osamu Yamaguchi
Journal:  Ther Adv Urol       Date:  2014-06

9.  Suppression of nitrosative and oxidative stress to reduce cardiac allograft vasculopathy.

Authors:  Tomomi Hasegawa; Koichiro Iwanaga; Donald E Hultquist; Hui Liao; Scott H Visovatti; David J Pinsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

10.  The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation.

Authors:  D J Pinsky; Y Naka; N C Chowdhury; H Liao; M C Oz; R E Michler; E Kubaszewski; T Malinski; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.